Corticosteroids directly reduce Staphylococcus aureus biofilm growth: An in vitro study

Laryngoscope

Volumn 124, Issue 3, 2014, Pages 602-607

  Goggin, Rachel ^a   Jardeleza, Camille ^a   Wormald, Peter John ^a   Vreugde, Sarah ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

biofilms; budesonide; Chronic rhinosinusitis; fluticasone; mometasone; Staphylococcus aureus; steroids

Indexed keywords

BIOFILMS; BUDESONIDE; CHRONIC RHINOSINUSITIS; FLUTICASONE; MOMETASONE; STAPHYLOCOCCUS AUREUS; STEROIDS;

ADRENAL CORTEX HORMONES; ANDROSTADIENES; BIOFILMS; BUDESONIDE; CULTURE MEDIA, CONDITIONED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PREGNADIENEDIOLS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84894452392     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.24322     Document Type: Article

References (36)

1. Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ,. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev 2011;(8): CD009274.
2. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008;(2): CD000243.
3. Levy SB,. The 2000 Garrod lecture. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother 2002; 49: 25-30.
4. Hooper DC, DeMaria A, Limbago BM, O'Brien TF, McCaughey B,. Antibiotic resistance: how serious is the problem, and what can be done? Clin Chem 2012; 58: 1182-1186.
5. Foreman A, Psaltis AJ, Tan LW, Wormald PJ,. Characterization of bacterial and fungal biofilms in chronic rhinosinusitis. Am J Rhinol Allergy 2009; 23: 556-561.
6. You H, Zhuge P, Li D, Shao L, Shi H, Du H,. Factors affecting bacterial biofilm expression in chronic rhinosinusitis and the influences on prognosis. Am J Otolaryngol 2011; 32: 583-590.
7. Brook I, Frazier E,. Correlation between microbiology and previous sinus surgery in patients with chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 2001; 110: 148-151.
8. Foreman A, Wormald PJ,. Different biofilms, different disease? A clinical outcomes study. Laryngoscope 2010; 120: 1701-1706.
9. Jervis-Bardy J, Foreman A, Field J, Wormald PJ,. Impaired mucosal healing and infection associated with Staphylococcus aureus after endoscopic sinus surgery. Am J Rhinol Allergy 2009; 23: 549-552.
10. Hall-Stoodley L, Costerton JW, Stoodley P,. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2: 95-108.
11. Tatar EC, Tatar I, Ocal B, et al. Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps. Otolaryngol Head Neck Surg 2012; 146: 669-675.
12. Foreman A, Holtappels G, Psaltis AJ, et al. Adaptive immune responses in Staphylococcus aureus biofilm-associated chronic rhinosinusitis. Allergy 2011; 66: 1449-1456.
13. Hamilos DL,. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol 2011; 128: 693-707; quiz 708-699.
14. Lal D, Hwang PH,. Oral corticosteroid therapy in chronic rhinosinusitis without polyposis: a systematic review. Int Forum Allergy Rhinol 2011; 1: 136-143.
15. Zeng M, Long XB, Cui YH, Liu Z,. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults. Am J Rhinol Allergy 2011; 25: e203-e207.
16. Funder J,. Corticosteroids-mechanism of action. Aust Prescr 1996; 19: 41-44.
17. Lavigne F, Cameron L, Renzi PM, et al. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 2002; 112: 858-864.
18. Derendorf H, Meltzer EO,. Molecular and clinical pharmacology of intranasal corticosteroids: clinical and therapeutic implications. Allergy 2008; 63: 1292-1300.
19. Jervis-Bardy J, Foreman A, Bray S, Tan L, Wormald PJ,. Methylglyoxal-infused honey mimics the anti-Staphylococcus aureus biofilm activity of manuka honey: potential implication in chronic rhinosinusitis. Laryngoscope 2011; 121: 1104-1107.
20. Jardeleza C, Foreman A, Baker L, et al. The effects of nitric oxide on Staphylococcus aureus biofilm growth and its implications in chronic rhinosinusitis. Int Forum Allergy Rhinol 2011; 1: 438-444.
21. Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A,. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37: 1771-1776.
22. Singhal D, Boase S, Field J, Jardeleza C, Foreman A, Wormald PJ,. Quantitative analysis of in vivo mucosal bacterial biofilms. Int Forum Allergy Rhinol 2012; 2: 57-62.
23. Psaltis AJ, Ha KR, Beule AG, Tan LW, Wormald PJ,. Confocal scanning laser microscopy evidence of biofilms in patients with chronic rhinosinusitis. Laryngoscope 2007; 117: 1302-1306.
24. Heydorn A, Ersboll BK, Hentzer M, Parsek MR, Givskov M, Molin S,. Experimental reproducibility in flow-chamber biofilms. Microbiology 2000; 146 (pt 10): 2409-2415.
25. Zeger SL, Liang KY, Albert PS,. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44: 1049-1060.
26. Ballinger GA,. Using generalized estimating equations for longitudinal data analysis. Organ Res Methods 2004; 7: 127-150.
27. Lavigne F, Tulic MK, Gagnon J, Hamid Q,. Selective irrigation of the sinuses in the management of chronic rhinosinusitis refractory to medical therapy: a promising start. J Otolaryngol 2004; 33: 10-16.
28. Wadhwani T, Desai K, Patel D, et al. Effect of various solvents on bacterial growth in context of determining MIC of various antimicrobials. Internet J Microbiol 2009;, 7,. Available at: http://archive.ispub.com/journal/ the-internet-journal-of-microbiology/volume-7-number-1/effect-of-various- solvents-on-bacterial-growth-in-context-of-determining-mic-of-various- antimicrobials.html#sthash.BG4t7lvY.dpbs. Accessed on May 7, 2013.
29. de Menorval M-A, Mir L, Fernandez M, Reigada R,. Effects of dimethyl sulfoxide in cholesterol-containing lipid membranes: a comparative study of experiments in silico and with cells. PLoS One 2012; 7: e41733.
30. Stepanovic S, Vukovic D, Hola V, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007; 115: 891-899.
31. Bendouah Z, Barbeau J, Hamad WA, Desrosiers M,. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 2006; 134: 991-996.
32. Snidvongs K, Pratt E, Chin D, Sacks R, Earls P, Harvey RJ,. Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol 2012; 2: 415-421.
33. Desrosiers M, Hussain A, Frenkiel S, et al. Intranasal corticosteroid use is associated with lower rates of bacterial recovery in chronic rhinosinusitis. Otolaryngol Head Neck Surg 2007; 136: 605-609.
34. Rudack C, Bachert C, Stoll W,. Effect of prednisolone on cytokine synthesis in nasal polyps. J Interferon Cytokine Res 1999; 19: 1031-1035.
35. Mullol J, Xaubet A, Lopez E, Roca-Ferrer J, Picado C,. Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 1995; 50: 270-274.
36. Robinson A, van Oijen AM,. Bacterial replication, transcription and translation: mechanistic insights from single-molecule biochemical studies. Nat Rev Microbiol 2013; 11: 303-315.